Abstract
Conclusions: High-dose IMRT with intraprostatic fiducial markers is associated with a very low toxicity and with a significant lower rate of GI and GU complications compared to 3DCRT even considering the lower follow-up for the IMRT cohort. These data confirms that this technique is safe to deliver radiation dose above 80 Gy. Author Disclosure: A. Zapatero: None. F. Garcia-Vicente: None. C. Matin de Vidales: None. G. Rodriguez: None. O. Leaman: None. R. Bermudez: None. A. Cruz-Conde: None. O. Linan: None. L. Perez: None. J. Torres: None.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have